New CAR t therapy targets Hard-to-Treat AL amyloidosis
NCT ID NCT07250269
First seen Dec 08, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This early-phase trial tests a new treatment called GC012F for people with AL amyloidosis that has come back or not responded to prior therapy. The therapy uses a patient's own immune cells, modified to target two proteins on harmful cells. The main goals are to check safety and see if the treatment can reduce or eliminate signs of the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY AL AMYLOIDOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGBeijing, 100034, China
-
Research Site
RECRUITINGBeijing, 100070, China
-
Research Site
RECRUITINGBeijing, CN-100730, China
-
Research Site
RECRUITINGChangchun, 130021, China
-
Research Site
RECRUITINGGuangzhou, 510100, China
-
Research Site
NOT_YET_RECRUITINGHangzhou, 310003, China
-
Research Site
RECRUITINGSuzhou, 215006, China
-
Research Site
RECRUITINGWenzhou, 325000, China
-
Research Site
NOT_YET_RECRUITINGWuhan, 430022, China
Conditions
Explore the condition pages connected to this study.